Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
School of Public Health and Community Medicine, Faculty of Medicine, UNSW Australia, Sydney, NSW, 2052, Australia, a.newall@unsw.edu.au.
A T
AT
Newall
M
M
Jit
R
R
Hutubessy
D006801:Humans; D032541:Mass Vaccination / Q000191:economics*; D014612:Vaccines / Q000191:economics*
D014612:Vaccines